These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Discovery of novel coumarin-based KRAS-G12C inhibitors from virtual screening and Rational structural optimization. Shi JT, Hou SJ, Cheng L, Zhang HJ, Mu HX, Wang QS, Wang ZY, Chen SW. Bioorg Chem; 2024 Jul; 148():107467. PubMed ID: 38772290 [Abstract] [Full Text] [Related]
4. Design, synthesis and pharmacological evaluation of bicyclic and tetracyclic pyridopyrimidinone analogues as new KRASG12C inhibitors. Xiao X, Lai M, Song Z, Geng M, Ding J, Xie H, Zhang A. Eur J Med Chem; 2021 Mar 05; 213():113082. PubMed ID: 33309163 [Abstract] [Full Text] [Related]
6. Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors. Liu TC, Peng X, Ma YC, Ji YC, Chen DQ, Zheng MY, Zhao DM, Cheng MS, Geng MY, Shen JK, Ai J, Xiong B. Acta Pharmacol Sin; 2016 May 05; 37(5):698-707. PubMed ID: 27041462 [Abstract] [Full Text] [Related]
13. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study. Lončar B, Perin N, Mioč M, Boček I, Grgić L, Kralj M, Tomić S, Stojković MR, Hranjec M. Eur J Med Chem; 2021 May 05; 217():113342. PubMed ID: 33751978 [Abstract] [Full Text] [Related]
14. Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor. Zhang L, Lakkaniga NR, Bharate JB, Mcconnell N, Wang X, Kharbanda A, Leung YK, Frett B, Shah NP, Li HY. Eur J Med Chem; 2021 Dec 05; 225():113776. PubMed ID: 34479037 [Abstract] [Full Text] [Related]
15. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents. Jiao Y, Xin BT, Zhang Y, Wu J, Lu X, Zheng Y, Tang W, Zhou X. Eur J Med Chem; 2015 Jan 27; 90():170-83. PubMed ID: 25461318 [Abstract] [Full Text] [Related]
16. Scaffold Hopping Approach to a New Series of Pyridine Derivatives as Potent Inhibitors of CDK2. Xu X, Yao Q. Arch Pharm (Weinheim); 2016 Mar 27; 349(3):224-31. PubMed ID: 26871934 [Abstract] [Full Text] [Related]
17. A novel Imidazo[1,2-a]pyridine derivative modulates active KRASG12D through off-like conformational shifts in switch-I and switch-II regions, mimicking inactive KRASG12D. Ali Y, Khan AA, Alanazi AM, Fatima S, Kozmon S. Int J Biol Macromol; 2024 Jun 27; 270(Pt 2):132477. PubMed ID: 38772459 [Abstract] [Full Text] [Related]